Heritas Capital

Tessa Therapeutics Pte Ltd. is a biotechnology company focused on developing innovative cancer immunotherapies, specifically targeting solid tumors. Founded in 2011 and based in Singapore, the company specializes in creating virus-specific T cells and CAR T cells aimed at treating lymphoma. By advancing these therapies, Tessa Therapeutics seeks to provide healthcare providers with effective options to improve the lives of cancer patients.

HealthBeats is a company focused on enhancing healthcare through regular remote patient monitoring. Their platform provides a user-friendly solution for health providers and patients, allowing individuals to self-administer medical devices at home from various brands. This technology enables the real-time transmission of health data to healthcare providers, facilitating proactive care management. By promoting consistent monitoring outside traditional healthcare settings, HealthBeats aims to improve patient outcomes and reduce healthcare costs, empowering patients to take an active role in managing their health and well-being.

Jio Health is a healthcare platform that offers users a comprehensive solution for managing their health. It enables individuals to track vital signs, manage medications, and access their health data by integrating with fitness and wearable devices. The platform provides on-demand access to various clinical services, including primary care, chronic disease management, pediatrics, and ancillary care services, allowing patients to receive immediate healthcare from the comfort of their homes. By facilitating the sharing of medical data with healthcare providers, Jio Health enhances the delivery of healthcare and supports users in maintaining their personal health profiles.

Cakap is an online language learning platform based in Jakarta, Indonesia, that facilitates interactive learning through video calls and text conversations between learners and professional tutors across the Asia Pacific. Founded in 2013 and originally known as SquLine, Cakap aims to provide accessible, high-quality education, focusing on enhancing life skills and conversational language proficiency. The platform connects students with native teachers, allowing them to study flexibly from home or the office while avoiding the challenges of traditional education, such as inconvenient scheduling and high costs. Cakap is committed to empowering individuals by making skill enhancement available to everyone, regardless of their location or time constraints.

Holmusk Pte. Ltd. is a digital health and data analytics company focused on delivering real-world evidence for mental health and chronic diseases. Founded in 2015 and headquartered in Singapore, with additional offices in New York, Durham, London, and Cyberjaya, Holmusk develops an analytics platform that integrates scientific research, electronic health records, and behavioral health data to provide predictive algorithms and actionable insights for personalized medicine. The company offers solutions such as MindLinc, an electronic health record system that enhances longitudinal data for advanced analytics, and digital therapeutics that monitor and treat patients. Holmusk's platform supports various stakeholders in the healthcare ecosystem, including pharmaceutical companies, healthcare providers, payers, and regulators, facilitating informed care decisions and improving treatment outcomes for individuals managing behavioral health conditions. Through its innovative approach, Holmusk aims to advance data-driven, evidence-based care and aid in the research and development of new therapies.

Pintek is a financial technology company aiming to democratise access to education in Indonesia through affordable and flexible credit.

ConveGenius is focused on nurturing and harnessing value by providing affordable educational solutions to create impact in large volumes. Their core competence lies in building mobile products/ apps/ games catered for global and local markets likewise. The company is focussed towards providing quality education to children at risk by integrating technology with education and working with state governments to penetrate the rural and semi urban areas of India. It also aims to cater to the global urban market using retailing and e-tailing channels for its various world-class high-end educational solutions. ConveGenius is based out of India and Singapore. Their India office is headquartered in Noida.

Mfine is an health-tech startup that offers an AI-powered online doctor consultation app. Their doctors have access to a proprietary Assistive Intelligence platform that can analyze the symptoms and deliver accurate prognosis for the specialist to assess patients. This means, the doctor knows about patients' condition even before they’ve seen them, making the diagnosis quicker and sharper. Mfine aims to make access to trusted healthcare simple, fast and proactive. With a combination of new-age technology and partnerships with best in class hospitals/clinics, they designed mfine keeping consumer experience at its core. Mfine brings in instant and continuous connectivity with top doctors of the best hospitals. It uses cutting edge technology to keep track of your health parameters and keep all your health data in your control and easily accessible. Digital wearable devices, mobile app, and at-home services bring in the much-needed convenience and speed in getting you the right care when you need it. Mfine was founded in 2017 and is based in Bengaluru.

Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

Mfine is an health-tech startup that offers an AI-powered online doctor consultation app. Their doctors have access to a proprietary Assistive Intelligence platform that can analyze the symptoms and deliver accurate prognosis for the specialist to assess patients. This means, the doctor knows about patients' condition even before they’ve seen them, making the diagnosis quicker and sharper. Mfine aims to make access to trusted healthcare simple, fast and proactive. With a combination of new-age technology and partnerships with best in class hospitals/clinics, they designed mfine keeping consumer experience at its core. Mfine brings in instant and continuous connectivity with top doctors of the best hospitals. It uses cutting edge technology to keep track of your health parameters and keep all your health data in your control and easily accessible. Digital wearable devices, mobile app, and at-home services bring in the much-needed convenience and speed in getting you the right care when you need it. Mfine was founded in 2017 and is based in Bengaluru.

Cakap is an online language learning platform based in Jakarta, Indonesia, that facilitates interactive learning through video calls and text conversations between learners and professional tutors across the Asia Pacific. Founded in 2013 and originally known as SquLine, Cakap aims to provide accessible, high-quality education, focusing on enhancing life skills and conversational language proficiency. The platform connects students with native teachers, allowing them to study flexibly from home or the office while avoiding the challenges of traditional education, such as inconvenient scheduling and high costs. Cakap is committed to empowering individuals by making skill enhancement available to everyone, regardless of their location or time constraints.

Alchemy Foodtech is a food science and technology company that develops novel active food ingredients that fights diabetes. The company believes the ideal healthcare system to diabetes is one that doesn't let you get it in the first place. By combining disruptive food, bio and medical technologies into everyday food, Alchemy Foodtech provides diabetics with far better disease management and also the general public with diabetes prevention.

Alodokter is a digital health platform that provides an end-to-end digital solution to patients including telemedicine, doctors, and others. It also provides credible information, supportive communities, and in-depth reference material about health subjects that matter to. The platform brings high-quality medical services to its 20 million+ Monthly Active Users by providing an integrated mobile solution for patients and doctors. Alodokter's medical services are fully integrated via an application that can be downloaded on Android and iOS to meet the health needs of the Indonesian public, the latest health content, chat with doctors, an online booking platform for consultation with doctors and/or looking for hospitals. It was founded in 2014 and is based in Jakarta, Indonesia.

SilverConnect is a medical nutrition startup creating specialized food solutions for people with dysphagia. Dysphagia, or the difficulty to swallow, is more common in older people and often results from nerve or muscle problems.

Holmusk Pte. Ltd. is a digital health and data analytics company focused on delivering real-world evidence for mental health and chronic diseases. Founded in 2015 and headquartered in Singapore, with additional offices in New York, Durham, London, and Cyberjaya, Holmusk develops an analytics platform that integrates scientific research, electronic health records, and behavioral health data to provide predictive algorithms and actionable insights for personalized medicine. The company offers solutions such as MindLinc, an electronic health record system that enhances longitudinal data for advanced analytics, and digital therapeutics that monitor and treat patients. Holmusk's platform supports various stakeholders in the healthcare ecosystem, including pharmaceutical companies, healthcare providers, payers, and regulators, facilitating informed care decisions and improving treatment outcomes for individuals managing behavioral health conditions. Through its innovative approach, Holmusk aims to advance data-driven, evidence-based care and aid in the research and development of new therapies.

Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

Alodokter is a digital health platform that provides an end-to-end digital solution to patients including telemedicine, doctors, and others. It also provides credible information, supportive communities, and in-depth reference material about health subjects that matter to. The platform brings high-quality medical services to its 20 million+ Monthly Active Users by providing an integrated mobile solution for patients and doctors. Alodokter's medical services are fully integrated via an application that can be downloaded on Android and iOS to meet the health needs of the Indonesian public, the latest health content, chat with doctors, an online booking platform for consultation with doctors and/or looking for hospitals. It was founded in 2014 and is based in Jakarta, Indonesia.

Pathstream is a web-based platform focused on teaching in-demand tech skills essential for the workforce. By partnering with leading tech companies and higher education institutions, Pathstream transforms digital skills learning through its innovative platform. This platform provides students with immediate access to pre-configured, project-based instruction, realistic workplace simulations, and on-demand coaching. By facilitating a hands-on learning experience, Pathstream enables students to acquire the necessary digital skills to thrive in today's economy.

Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.

ReUp Education, Inc. is a San Francisco-based company that focuses on re-enrolling students who have left college, aiming to increase graduation rates and boost tuition revenue for educational institutions. Founded in 2015, ReUp employs data, technology, and personalized coaching to assist these students in overcoming various barriers to completion, such as financial challenges, work commitments, and lack of motivation. The company collaborates with universities and community colleges to identify and engage students who have discontinued their education, providing them with essential support services including goal-setting, financial management, and career preparation. By helping these individuals navigate their path back to graduation, ReUp Education addresses a significant issue in higher education, where millions of students drop out each year, leaving behind substantial debt and diminished career prospects.

Alchemy Foodtech is a food science and technology company that develops novel active food ingredients that fights diabetes. The company believes the ideal healthcare system to diabetes is one that doesn't let you get it in the first place. By combining disruptive food, bio and medical technologies into everyday food, Alchemy Foodtech provides diabetics with far better disease management and also the general public with diabetes prevention.

Alchemy Foodtech is a food science and technology company that develops novel active food ingredients that fights diabetes. The company believes the ideal healthcare system to diabetes is one that doesn't let you get it in the first place. By combining disruptive food, bio and medical technologies into everyday food, Alchemy Foodtech provides diabetics with far better disease management and also the general public with diabetes prevention.

Holmusk Pte. Ltd. is a digital health and data analytics company focused on delivering real-world evidence for mental health and chronic diseases. Founded in 2015 and headquartered in Singapore, with additional offices in New York, Durham, London, and Cyberjaya, Holmusk develops an analytics platform that integrates scientific research, electronic health records, and behavioral health data to provide predictive algorithms and actionable insights for personalized medicine. The company offers solutions such as MindLinc, an electronic health record system that enhances longitudinal data for advanced analytics, and digital therapeutics that monitor and treat patients. Holmusk's platform supports various stakeholders in the healthcare ecosystem, including pharmaceutical companies, healthcare providers, payers, and regulators, facilitating informed care decisions and improving treatment outcomes for individuals managing behavioral health conditions. Through its innovative approach, Holmusk aims to advance data-driven, evidence-based care and aid in the research and development of new therapies.